1-3 of 3
Keywords: Leuprorelin acetate
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Health-Related Quality of Life in 536 Long-Term Prostate Cancer Survivors after Treatment with Leuprorelin Acetate: A Combined Retrospective and Prospective Analysis

Available to Purchase
Subject Area:
Further Areas
Peter G. Hammerer, Manfred P. Wirth, on behalf of the ENA E005/DE-N-LEU-019 study group
Journal: Urologia Internationalis
Urol Int (2018) 100 (1): 72–78.
https://doi.org/10.1159/000479434
Published Online: 25 November 2017
...Peter G. Hammerer; Manfred P. Wirth; on behalf of the ENA E005/DE-N-LEU-019 study group Introduction: We investigated the health-related quality of life (HRQoL) of long-term prostate cancer patients who received leuprorelin acetate in microcapsules (LAM) for androgen-deprivation therapy (ADT...
View article titled, Health-Related Quality of Life in 536 Long-Term Prostate Cancer Survivors after Treatment with Leuprorelin Acetate: A Combined Retrospective and Prospective Analysis
Open the PDF for Health-Related Quality of Life in 536 Long-Term Prostate Cancer Survivors after Treatment with Leuprorelin Acetate: A Combined Retrospective and Prospective Analysis in another window
Journal Articles

Clinical Study Results of the New Formulation Leuprorelin Acetate Three-Month Depot for the Treatment of Advanced Prostate Carcinoma

Available to Purchase
Subject Area:
Further Areas
P. Fornara, D. Jocham
Journal: Urologia Internationalis
Urol Int (1996) 56 (Suppl. 1): 18–22.
https://doi.org/10.1159/000282864
Published Online: 04 February 2010
...P. Fornara; D. Jocham Androgen suppression, using gonadotrophin-releasing hormone analogues (leuprorelin), is being developed as an effective treatment of advanced prostate carcinoma. Treatment with leuprorelin acetate 1-month depot is already well established all over the world. In order...
View article titled, Clinical Study Results of the New Formulation Leuprorelin Acetate Three-Month Depot for the Treatment of Advanced Prostate Carcinoma
Open the PDF for Clinical Study Results of the New Formulation Leuprorelin Acetate Three-Month Depot for the Treatment of Advanced Prostate Carcinoma in another window
Journal Articles

Leuprorelin Three-Month Depot in the Treatment of Advanced and Metastatic Prostate Cancer: Long-Term Follow-Up Results

Available to Purchase
Subject Area:
Further Areas
Dieter Jocham
Journal: Urologia Internationalis
Urol Int (1998) 60 (Suppl. 2): 18–24.
https://doi.org/10.1159/000056547
Published Online: 20 April 1998
...Dieter Jocham Objectives: To determine median survival time, median time to tumor progression and maintenance of testosterone suppression (i.e. ≤50 ng/dl) during long-term treatment with subcutaneous injections of leuprorelin acetate 3-month depot (LAD-3M). In Germany 62 patients with advanced...
View article titled, Leuprorelin Three-Month Depot in the Treatment of Advanced and Metastatic Prostate Cancer: Long-Term Follow-Up Results
Open the PDF for Leuprorelin Three-Month Depot in the Treatment of Advanced and Metastatic Prostate Cancer: Long-Term Follow-Up Results in another window